A top-notch R&D team, including American Cyokin Group, the University of Southern California, cell and gene scientists from Harvard, Yale, and Stanford, Professor Qilong Ying, chief scientist of Cyokin Group and Nobel Prize-winning scientist, and Professor Xiaojun Liu, chief scientist of the University of Edinburgh, UK, has worked together for twenty years at the group's six R&D centers worldwide to develop the world's first super-targeted immune cell PM-NKT composite cell technology.